ADGRV1 and retinitis pigmentosa 1: Collectively, our findings indicate that excision of ADGRV1 exons 40–42 represents a promising therapeutic strategy for ADGRV1-associated RP and demonstrate how 3D structural modeling can facilitate the identification of additional target regions suitable for therapeutic exon excision or skipping approaches.